Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum

J Cosmet Dermatol. 2015 Sep;14(3):209-15. doi: 10.1111/jocd.12148. Epub 2015 Aug 7.

Abstract

Background: There are numerous methods currently available for the management of xanthelasma. These include surgical excision, laser ablation using a variety of lasers and chemical cauterization. However, each method of treatment is associated with particular limitations and side effects.

Objectives: To assess the clinical efficacy and tolerability of different concentrations of topical trichloroacetic acid (TCA) vs. carbon dioxide laser in the treatment of patients with xanthelasma palpebrarum.

Methods: Thirty patients with xanthelasma palpebrarum were classified into four groups, treated by TCA 35%, 50%, 70%, and CO2 laser, respectively. Lipid profile was estimated for all patients.

Results: Both TCA peeling 70% and carbon dioxide laser ablation showed more significant clinical efficacy and tolerability with least number of sessions in the treatment of xanthelasma palpebrarum than 50% and 35% TCA peeling. Post-therapy erythema and hypopigmentation were more with TCA 70%. Post-therapy hyperpigmentation was more with TCA (50%). There was a significant improvement in patients with normal lipid profile than those with abnormal profile.

Conclusion: Both TCA peeling 70% and carbon dioxide laser ablation are highly effective and well tolerated with least number of sessions in the treatment of xanthelasma palpebrarum.

Keywords: CO2 laser; efficacy; trichloroacetic acid.

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Chemexfoliation
  • Dermatologic Agents / administration & dosage*
  • Dermatologic Agents / adverse effects
  • Erythema / etiology
  • Facial Dermatoses / drug therapy
  • Facial Dermatoses / metabolism
  • Facial Dermatoses / therapy*
  • Female
  • Humans
  • Hypopigmentation / etiology
  • Lasers, Gas / adverse effects
  • Lasers, Gas / therapeutic use*
  • Lipid Metabolism
  • Trichloroacetic Acid / administration & dosage*
  • Trichloroacetic Acid / adverse effects
  • Xanthomatosis / drug therapy
  • Xanthomatosis / metabolism
  • Xanthomatosis / therapy*

Substances

  • Dermatologic Agents
  • Trichloroacetic Acid